In a double-blind study, 107 patients undergoing elective and emergency surgical procedures were given 15 ml of either sodium citrate 0·3 M or placebo 10 minutes before induction of anaesthesia. Gastric contents were sampled immediately after induction and the pH was measured. The mean pH of the gastric contents of patients given sodium citrate was 5· 67, whereas for those given the placebo it was 3·21 (p < 0·001). Of patients given sodium citrate 92% had a gastric pH above 3·0 compared with only 37% in the placebo group (p < 0·001). At the end of surgery gastric contents were emptied as completely as possible and the volume and pH measured. There was no significant difference in the mean volume of gastric contents in the two groups. In neither group was the mean pH at the end of surgery significantly different from that after induction.
Oral magnesium trisilicate has been used for many years for prophylaxis against aspiration pneumonitis. Recent reports in both animals l and humans 2 indicate, however, that magnesium trisilicate may itself be harmful if it is aspirated into the lungs.
Sodium citrate, an antacid, has been shown to produce no permanent lung damage on aspiration in dogs, I and it has been suggested that sodium citrate may be a suitable antacid to replace magnesium trisilicate.
The present study was designed to assess the effect of sodium citrate administered preoperatively on gastric pH after induction of anaesthesia and at the end of surgery and on the volume of the gastric contents at the end of operation. METHODS 107 patients undergoing orthopaedic, gyneacological, urological and general surgical operations were randomly divided into two groups on a double-blind basis. Of the patients, 76 presented for emergency surgery. Informed consent was obtained. Patients on antacids or cimetidine therapy were excluded from the study.
Premedication consisted of omnopon 0·3 mg/kg or pethidine 1·5 mg/kg intramuscularly. Ten minutes before induction the patients were given orally either 15 ml of 0·3M sodium citrate in chloroform water (aniseed flavour) or 15 ml of 10070 aniseed flavoured chloroform water from identical containers. All patients were asked whether the taste was pleasant or unpleasant.
After pre-oxygenation for three minutes anaesthesia was induced with sodium thiopentone 4·0 mg/kg, cricoid pressure Anaesthesia and Intensive Care, Va!. X, No. 2, May, 1982 applied, and suxamethonium (1 mg/kg) administered. Rapid intubation with an appropriate size oral endotracheal tube was performed. Anaesthesia was maintained on nitrous oxide and oxygen supplemented with either halothane or phenoperidine. Pancuronium or d-tubocurarine were used for muscle relaxation. A Ryle's tube (FI4-18) was inserted via the nose into the stomach immediately after intubation. Correct placement of Ryle's tube was confirmed by injecting 5 ml of air and listening over the stomach.
Within 30 minutes of receiving antacid or placebo, 5 ml of gastric contents was collected and its pH measured using a Copenhagen radiometer PHM 62. At the end of operation, just prior to reversal of relaxants, gastric contents were aspirated as completely as possible and the pH and volume measured. Routine clinical monitoring was continued throughout surgery and in the recovery room postoperatively. The duration of the anaesthesia was recorded. In vitro study 1. Random samples of the bulk supply of sodium citrate and placebo were tested for pH at monthly intervals for 12 months. 2. Sodium citrate 0·3M was titrated with HCI (pH 1·4) at 37 QC by means of burrette until the pH of sodium citrate fell to 3·0, the pH being measured with the same pH meter mentioned above. The same titration was performed for the placebo solution.
RESULTS
The characteristics of the patients are summarised in Table 1 . The two groups were reasonably well matched for age, weight and sex. Table 2 shows the number of emergency and elective cases in both the placebo and the citrate treated groups, and the mean duration of anaesthesia for each subgroup. The mean gastric volume and pH from both groups are shown in Table 3 . There was no statistical difference in gastric volumes between the two groups (unpaired t-test). There is also no statistical difference between gastric pH at the beginning and the end of operation within either the placebo or citrate-treated group (paired t-test). However, there are significant differences when the pH of gastric contents of the placebo and citrate groups are compared both after induction and at the end of surgery (p < 0·001, unpaired t-test).
Sodium citrate Placebo
After induction, in the citrate group 56 patients (920,10) had gastric contents of pH greater than 3·0 but only 17 (37%) of the placebo group had gastric contents with a pH above 3·0. This difference proved to be significant using the chi square test 5% of the patients complained that sodium citrate solution was unpleasant.
No adverse effects which could be attributed to sodium citrate were seen during the preoperative, operative and postoperative period.
In vitro study
The pH of sodium citrate and placebo solution remained constant at 8·5 and 6·5 respectively throughout the 12-month period of the study. On titration it was found that 286 ml of HCI (pH 1·4) was required to lower the pH of 15 ml of 0·3 molar citrate from 8·5 to 3·0, whereas only 1·7 ml of the same HCl was required to lower the pH of similar volume of placebo solution from 6·5 to 3·0.
DISCUSSION
The severity of aspiration pneumonitis depends on the pH, volume and content of what is aspirated. Teabeault showed that the critical pH was 2·5 below which the symptoms became severe. 3 Crawford has recently suggested that pH 3·0 should be regarded as the critical level. 4 By this criterion, our study showed that sodium citrate should result in reduced risk of severe pneumonitis in patients undergoing elective and emergency surgery. A similar study by Lahiri also showed that sodium citrate is effective in reducing the acidity of gastric contents. 5 Roberts and Shirley considered a volume of 0·4 mllkg of gastric juice was necessary to create the risk of aspiration pneumonitis. 6 The mean gastric volumes were 28 and 31 ml in the placebo and citrate group respectively. This suggests that our patients in both groups were at risk. The measurement of the volume of gastric contents by evacuation, as we have used, underestimates the volume when compared with a dye dilution technique. This would indicate that the risk of aspiration is even greater than our measured volumes would suggest. It is therefore emphasised that other measures such as adequate fasting and cricoid pressure must also be employed when appropriate.
Cimetidine, an H2 histamine receptor antagonist, when given orally or parentally with premedication, can raise gastric pH above 3·0 in the majority of patients. 8 -1O Serious sideeffects of cimetidine are rare, though they have been reported in association with prolonged treatment.
They include dangerous arrhythmias,II-13 thrombocytopenia,14 increased fibrinolysis,15 coma and mental confusion in ill patients. 16 ,17 Because of these serious sideeffects we believe cimetidine may not be a safe agent to be used for prophylaxis against aspiration pneumonitis. To date no such dangers have been reported with sodium citrate.
Sodium citrate is easily prepared and relatively cheap compared with cimetidine. Our study shows that it can be stored at room temperature for as long as 12 months without any change in pH. Most people find it pleasant to taste when aniseed-flavoured.
In dog experiments Gibbs showed that sodium citrate in glucose or saline when aspirated is less toxic to the lungs than emulsion antacids. I After a month the histological picture of the lungs instilled with sodium citrate was normal whereas in lungs instilled with emulsion antacids, inflammatory reaction was still present.
We recommend that sodium citrate be used as an alternative antacid for the prevention of aspiration pneumonitis.
